Antiresorptive Drug–Related Osteonecrosis of the Jaw - 21/03/14
Résumé |
Nitrogen-containing and non–nitrogen-containing bisphosphonates have been implicated in the development of osteonecrosis of the jaw (ONJ), a condition termed bisphosphonate-related OHJ. Other antiresorptive drugs have been implicated in the development of OHJ, hence the new term antiresorptive drug–related ONJ. The underlying pathogenesis remains unclear, and no definite diagnosis or cure has been established for this debilitating condition. This article reviews some of the most common antiresorptive drugs with their associated risks of ONJ and the current understanding of the pathogenesis ONJ, and summarizes current clinical guidelines.
Le texte complet de cet article est disponible en PDF.Keywords : Bisphosphonate, Denosumab, Osteonecrosis of the jaw, Zoledronate
Plan
The authors have nothing to disclose. |
Vol 58 - N° 2
P. 369-384 - avril 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?